Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours. 1977

R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest

UI MeSH Term Description Entries
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D010546 Perphenazine An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE. Chlorpiprazine,Perfenazine,Trilafon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D004971 Estrus The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
D005260 Female Females

Related Publications

R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
December 1977, European journal of cancer,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
April 1982, Scandinavian journal of clinical and laboratory investigation,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
January 1971, Oncology,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
April 1982, Scandinavian journal of clinical and laboratory investigation,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
January 1973, Oncology,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
November 1975, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
July 1983, The Journal of endocrinology,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
May 1977, British journal of cancer,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
May 1978, The Journal of endocrinology,
R A Hawkins, and A Hill, and B Freedman, and E Killen, and P Buchan, and W R Miller, and A P Forrest
January 1989, Pharmacological research,
Copied contents to your clipboard!